ARCHIVES

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

This article is from The Cancer Letter archive.

Vol. 38 No. 02 | January 13, 2012

Download PDF Visit The Full Archive

Related Articles

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Impeding Reagan Budget Cuts Feared By Cancer Program Advocates; DeVita Asks Parity With NIH

February 13, 1981

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012

Fellowships In Japan Available Through NIH

October 13, 1995

In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director

July 29, 1988

In Brief: Henney Names Acting Director Of DRCCA: House Bill Would Slash Deeply Into Research Using Animals

September 11, 1981